$ATEN
A10 Networks, Inc.

2014 Q4 Form 10-Q Financial Statement

#000158080814000026 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $45.20M $43.43M $39.83M
YoY Change 7.11% 9.04% 27.16%
Cost Of Revenue $10.79M $11.75M $8.734M
YoY Change -3.14% 34.57% 37.33%
Gross Profit $34.41M $31.68M $31.09M
YoY Change 10.79% 1.88% 24.57%
Gross Profit Margin 76.13% 72.94% 78.07%
Selling, General & Admin $33.55M $29.79M $21.96M
YoY Change 31.52% 35.65% 46.32%
% of Gross Profit 97.5% 94.06% 70.64%
Research & Development $14.49M $12.34M $8.517M
YoY Change 66.17% 44.91% 25.81%
% of Gross Profit 42.11% 38.96% 27.39%
Depreciation & Amortization $2.780M $2.600M $1.800M
YoY Change 33.65% 44.44% -53.0%
% of Gross Profit 8.08% 8.21% 5.79%
Operating Expenses $48.04M $43.04M $32.16M
YoY Change 40.3% 33.83% 47.6%
Operating Profit -$13.63M -$11.37M -$1.070M
YoY Change 328.62% 962.52% -133.75%
Interest Expense -$1.370M $192.0K $1.399M
YoY Change 87.67% -86.28% 899.29%
% of Operating Profit
Other Income/Expense, Net -$702.0K -$1.472M
YoY Change -52.31%
Pretax Income -$15.26M -$12.07M -$2.542M
YoY Change 174.95% 374.86% -6.89%
Income Tax $760.0K $233.0K $207.0K
% Of Pretax Income
Net Earnings -$16.02M -$12.30M -$2.749M
YoY Change 186.07% 347.58% -6.5%
Net Earnings / Revenue -35.44% -28.33% -6.9%
Basic Earnings Per Share -$0.21 -$0.38
Diluted Earnings Per Share -$262.2K -$0.21 -$0.38
COMMON SHARES
Basic Shares Outstanding 60.72M shares 59.91M shares 9.308M shares
Diluted Shares Outstanding 59.91M shares 9.308M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $91.90M $107.1M $30.40M
YoY Change 341.83% 252.3%
Cash & Equivalents $91.91M $107.1M $30.36M
Short-Term Investments
Other Short-Term Assets $4.700M $4.900M $3.000M
YoY Change 74.07% 63.33%
Inventory $20.70M $19.37M $15.40M
Prepaid Expenses
Receivables $54.00M $42.47M $30.80M
Other Receivables $0.00 $0.00 $1.700M
Total Short-Term Assets $171.3M $173.9M $81.30M
YoY Change 117.66% 113.88%
LONG-TERM ASSETS
Property, Plant & Equipment $10.78M $11.84M $9.500M
YoY Change 9.99% 24.6%
Goodwill $72.00K
YoY Change
Intangibles
YoY Change
Long-Term Investments $700.0K
YoY Change
Other Assets $4.859M $4.629M $1.400M
YoY Change -7.87% 230.64%
Total Long-Term Assets $15.64M $16.47M $12.60M
YoY Change 3.74% 30.68%
TOTAL ASSETS
Total Short-Term Assets $171.3M $173.9M $81.30M
Total Long-Term Assets $15.64M $16.47M $12.60M
Total Assets $187.0M $190.4M $93.90M
YoY Change 99.35% 102.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.994M $11.18M $5.300M
YoY Change -2.54% 110.85%
Accrued Expenses $22.44M $19.99M $29.10M
YoY Change 44.61% -31.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $70.69M $66.15M $56.30M
YoY Change 11.15% 17.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $25.00M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.766M $1.974M $18.00M
YoY Change -71.13% -89.03%
Total Long-Term Liabilities $1.766M $1.974M $43.00M
YoY Change -71.13% -95.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.69M $66.15M $56.30M
Total Long-Term Liabilities $1.766M $1.974M $43.00M
Total Liabilities $90.42M $84.70M $99.30M
YoY Change -11.79% -14.7%
SHAREHOLDERS EQUITY
Retained Earnings -$181.8M -$165.8M
YoY Change 23.61%
Common Stock $1.000K $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $96.57M $105.7M -$5.400M
YoY Change
Total Liabilities & Shareholders Equity $187.0M $190.4M $93.90M
YoY Change 99.35% 102.72%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$16.02M -$12.30M -$2.749M
YoY Change 186.07% 347.58% -6.5%
Depreciation, Depletion And Amortization $2.780M $2.600M $1.800M
YoY Change 33.65% 44.44% -53.0%
Cash From Operating Activities -$17.02M -$3.800M -$6.630M
YoY Change 280.76% -42.68% 162.06%
INVESTING ACTIVITIES
Capital Expenditures -$720.0K -$1.590M -$980.0K
YoY Change 554.55% 62.24% -73.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$720.0K -$1.590M -$980.0K
YoY Change 554.55% 62.24% -73.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.540M 390.0K -20.40M
YoY Change -151.0% -101.91% -451.12%
NET CHANGE
Cash From Operating Activities -17.02M -3.800M -6.630M
Cash From Investing Activities -720.0K -1.590M -980.0K
Cash From Financing Activities 2.540M 390.0K -20.40M
Net Change In Cash -15.20M -5.000M -28.01M
YoY Change 59.0% -82.15% 6413.95%
FREE CASH FLOW
Cash From Operating Activities -$17.02M -$3.800M -$6.630M
Capital Expenditures -$720.0K -$1.590M -$980.0K
Free Cash Flow -$16.30M -$2.210M -$5.650M
YoY Change 273.85% -60.88% -578.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2419000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10485000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41080000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45634000 shares
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11175000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9228000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42474000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37704000 USD
CY2014Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
200000 USD
CY2013Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
100000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15514000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19994000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16091000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23013000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12185000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
271417000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2738000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10679000 shares
CY2014Q3 us-gaap Assets
Assets
190350000 USD
CY2013Q4 us-gaap Assets
Assets
93794000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
78719000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
173884000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
366000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
430000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107099000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20793000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6276000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4434000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23867000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30360000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
86306000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6493000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65600000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10032000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60509000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12845000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12500000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10032000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60509000 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. Our cash and cash equivalents are invested in high-credit quality financial instruments with banks and financial institutions. Management believes that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, are subject to minimal credit risk. Such deposits may be in excess of insured limits provided on such deposits.</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations of our customers to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable. We have recorded an allowance for doubtful accounts for those receivables that we have determined not to be collectible.</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenue for each period presented, or our gross accounts receivable balance as of each respective balance sheet date.</font></div></div>
CY2014Q1 us-gaap Contractual Obligation
ContractualObligation
12000000 USD
CY2014Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
39997114 shares
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32146000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8734000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22252000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11753000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6669000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
16469000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
23655000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8818000 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
2065000 USD
us-gaap Cost Of Services
CostOfServices
5783000 USD
us-gaap Cost Of Services
CostOfServices
8491000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
2935000 USD
CY2014Q3 us-gaap Deferred Revenue
DeferredRevenue
50902000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
41232000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
34329000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28448000 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16573000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
12784000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7337000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5000000 USD
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2600000 USD
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1800000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7200000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.43
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.43
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9015000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12990000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28700000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M8D
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-700000 USD
CY2013Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-100000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-500000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1400000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
159000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
230000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6993000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2014Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
7000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-128000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5141000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11213000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3686000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16035000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
31675000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
31092000 USD
us-gaap Gross Profit
GrossProfit
77286000 USD
us-gaap Gross Profit
GrossProfit
102159000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17955000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20909000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12071000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2542000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9670000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
586000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
747000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-523000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4109000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4771000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7898000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4102000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3138000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4531000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6832000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2993000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
197000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-209000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3303000 USD
CY2014Q1 us-gaap Initial Offering Period
InitialOfferingPeriod
In March 2014
CY2013Q3 us-gaap Interest Expense
InterestExpense
1399000 USD
us-gaap Interest Expense
InterestExpense
1445000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
192000 USD
us-gaap Interest Expense
InterestExpense
904000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6541000 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9806000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
19371000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
17166000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10625000 USD
CY2014Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
9565000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
102499000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
84699000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93794000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
190350000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
66152000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63597000 USD
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
20000000 USD
CY2014Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2014Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
654000 USD
CY2013Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
10407000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-3103000 USD
CY2014Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
910000 USD
CY2013Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1683000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
9887000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30032000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105207000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5380000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2876000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20663000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13521000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21495000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18702000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-12304000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2749000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19852000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22283000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12304000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3504000 USD
CY2014Q3 us-gaap Noncurrent Assets
NoncurrentAssets
12870000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10862000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1472000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-702000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2882000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1577000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
43044000 USD
us-gaap Operating Expenses
OperatingExpenses
95313000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
32162000 USD
us-gaap Operating Expenses
OperatingExpenses
118537000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18027000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1070000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16378000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11369000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4343000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4206000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5274000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4629000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6118000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1974000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5380000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2876000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1150000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
788000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3056000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4940000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
70000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
192700000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
79441000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
34002000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-222000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-229000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
813000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25892000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34850000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11837000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9801000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
4072000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
3370000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1150000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
32165000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20942000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11827000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
70000000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
631000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12342000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8517000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35416000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24625000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165767000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147065000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2000000 USD
CY2014Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
800000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
3600000 USD
CY2013Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1000000 USD
CY2013Q3 us-gaap Revenues
Revenues
39826000 USD
CY2014Q3 us-gaap Revenues
Revenues
43428000 USD
us-gaap Revenues
Revenues
134305000 USD
us-gaap Revenues
Revenues
99538000 USD
CY2014Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
15.00
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
31601000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
78596000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
32263000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
102140000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
99538000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
43428000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
39826000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
134305000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7563000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.74
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35753000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.14
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
58515000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8704000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9971000 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70189000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24651000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18276000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49588000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8314000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2880000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1153000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3538000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1500000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13900000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
806000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1264000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.55
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
27229000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4548000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.14
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
35174000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8355000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.40
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.87
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.36
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M26D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9153000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y4M26D
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7536000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-134880000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7600000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1725000 shares
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
105651000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2156000 USD
CY2014Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2798000 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-1150000 USD
CY2013Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-755000 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-788000 USD
CY2014Q3 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1800000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2300000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, sales return reserve, valuation of inventory, contingencies and litigation, and determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9308000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59913000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44538000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9153000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59913000 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9308000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44538000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59913000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9308000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9153000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44538000 shares
us-gaap Year Founded
YearFounded
2004
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
150000 USD
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
146000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-673000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-1437000 USD
CY2013Q3 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-73000 USD
CY2014Q3 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-510000 USD
CY2014Q2 aten Net Proceeds From Issuance Of Initial Public Offering After Deducting Underwriting Discounts And Commissions And Offering Costs
NetProceedsFromIssuanceOfInitialPublicOfferingAfterDeductingUnderwritingDiscountsAndCommissionsAndOfferingCosts
120200000 USD
CY2014Q2 aten Payments Related To Settlement
PaymentsRelatedToSettlement
5000000 USD
aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
556000 USD
aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
422000 USD
aten Proceeds From Exercise Of Common Stock Options Net Of Repurchases Of Common Stock
ProceedsFromExerciseOfCommonStockOptionsNetOfRepurchasesOfCommonStock
-4399000 USD
aten Proceeds From Exercise Of Common Stock Options Net Of Repurchases Of Common Stock
ProceedsFromExerciseOfCommonStockOptionsNetOfRepurchasesOfCommonStock
-1664000 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
121037000 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
-35000 USD
aten Reclassification Of The Convertible Preferred Stock Warrant Liability To Additional Paid In Capital Upon The Exercise Of The Convertible Preferred Stock Warrants
ReclassificationOfTheConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapitalUponTheExerciseOfTheConvertiblePreferredStockWarrants
0 USD
aten Reclassification Of The Convertible Preferred Stock Warrant Liability To Additional Paid In Capital Upon The Exercise Of The Convertible Preferred Stock Warrants
ReclassificationOfTheConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapitalUponTheExerciseOfTheConvertiblePreferredStockWarrants
2199000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60715534 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
dei Trading Symbol
TradingSymbol
ATEN

Files In Submission

Name View Source Status
0001580808-14-000026-index-headers.html Edgar Link pending
0001580808-14-000026-index.html Edgar Link pending
0001580808-14-000026.txt Edgar Link pending
0001580808-14-000026-xbrl.zip Edgar Link pending
aten-20140930.xml Edgar Link completed
aten-20140930.xsd Edgar Link pending
aten-20140930_cal.xml Edgar Link unprocessable
aten-20140930_def.xml Edgar Link unprocessable
aten-20140930_lab.xml Edgar Link unprocessable
aten-20140930_pre.xml Edgar Link unprocessable
aten-2014930x10q.htm Edgar Link pending
exhibit3112014930.htm Edgar Link pending
exhibit3122014930.htm Edgar Link pending
exhibit3212014930.htm Edgar Link pending
exhibit3222014930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending